Talk:Cadila Pharmaceuticals
This is the talk page for discussing improvements to the Cadila Pharmaceuticals article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
This article is written in Indian English, which has its own spelling conventions (colour, travelled, centre, analysed, defence) and some terms that are used in it may be different or absent from other varieties of English. According to the relevant style guide, this should not be changed without broad consensus. |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
Categories:
- Wikipedia articles that use Indian English
- Start-Class India articles
- Low-importance India articles
- Start-Class India articles of Low-importance
- Start-Class Gujarat articles
- High-importance Gujarat articles
- Start-Class Gujarat articles of High-importance
- WikiProject Gujarat articles
- WikiProject India articles
- Start-Class pharmacology articles
- High-importance pharmacology articles
- WikiProject Pharmacology articles
- Start-Class company articles
- High-importance company articles
- WikiProject Companies articles
- Start-Class AfC articles
- AfC submissions by date/27 May 2014
- Accepted AfC submissions